It's going to be very interesting next year to see what Follica can actually do.
Because if it proves to be a viable alternative to transplants, then Riken is dead in the water at this price point.
f*****g nobody would pay for this (even if they could afford it) when a way cheaper, effective alternative exists. This is equivalent to paying off a house upfront, for f***'s sake.
Basically, if that price is real, they may as well just publish their findings and then sit on it until the day comes where they can offer it for a competitive price.
Because if it proves to be a viable alternative to transplants, then Riken is dead in the water at this price point.
f*****g nobody would pay for this (even if they could afford it) when a way cheaper, effective alternative exists. This is equivalent to paying off a house upfront, for f***'s sake.
Basically, if that price is real, they may as well just publish their findings and then sit on it until the day comes where they can offer it for a competitive price.